|
|
| Mark your calendar for BioFuture™ 2025! | BioFuture returns to New York City this October, bringing together pioneers, investors, and decision-makers who are redefining the future of medicine. This year’s summit will focus on the convergence of biopharma, digital medicine, big data, and TechBio. With 600+ attendees, 100+ speakers, and 80+ presenting companies. Learn more and register. |
|
|
|
|
On this Business of Biotech episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix, talks about his personal journey standing up and growing a radiopharmaceutical company focused on oncology. |
|
|
|
|
|
|
|
|
|
| Inclusive Trial Design A 'Must-Have' In Modern R&D | The call for greater diversity in clinical trials has grown louder. Inclusivity in trial design is crucial for the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health. |
|
|